Georgia Li

1.1k total citations · 1 hit paper
4 papers, 290 citations indexed

About

Georgia Li is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Georgia Li has authored 4 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Georgia Li's work include Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). Georgia Li is often cited by papers focused on Liver Diseases and Immunity (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). Georgia Li collaborates with scholars based in United States, Austria and United Kingdom. Georgia Li's co-authors include Michael Trauner, Robert P. Myers, G. Mani Subramanian, Kris V. Kowdley, Jen‐Chieh Chuang, Kosh Agarwal, Charles Landis, Bilal Hameed, Mitchell L. Shiffman and Andrew J. Muir and has published in prestigious journals such as Hepatology, Clinical Gastroenterology and Hepatology and Hepatology Communications.

In The Last Decade

Georgia Li

4 papers receiving 284 citations

Hit Papers

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgia Li United States 4 214 193 116 98 38 4 290
Xiaomin Lu United States 6 210 1.0× 225 1.2× 141 1.2× 118 1.2× 24 0.6× 16 307
Seung Kak Shin South Korea 11 170 0.8× 156 0.8× 60 0.5× 39 0.4× 22 0.6× 34 289
Shunji Hirose Japan 11 128 0.6× 141 0.7× 60 0.5× 61 0.6× 36 0.9× 35 233
Ryuta Shigefuku Japan 10 167 0.8× 115 0.6× 43 0.4× 53 0.5× 39 1.0× 41 294
Zheng‐Rong Shi China 9 169 0.8× 140 0.7× 79 0.7× 30 0.3× 22 0.6× 23 291
Hidetaka Fujinaga Japan 6 164 0.8× 42 0.2× 114 1.0× 63 0.6× 73 1.9× 12 243
Rooshi Nathwani United Kingdom 8 210 1.0× 187 1.0× 74 0.6× 53 0.5× 10 0.3× 14 324
Nehad Hawash Egypt 10 237 1.1× 224 1.2× 59 0.5× 31 0.3× 12 0.3× 27 357
Ryoichi Narita Japan 8 104 0.5× 97 0.5× 97 0.8× 36 0.4× 23 0.6× 30 257
Ganesh Bhat India 10 149 0.7× 86 0.4× 109 0.9× 41 0.4× 59 1.6× 37 268

Countries citing papers authored by Georgia Li

Since Specialization
Citations

This map shows the geographic impact of Georgia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia Li more than expected).

Fields of papers citing papers by Georgia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia Li. The network helps show where Georgia Li may publish in the future.

Co-authorship network of co-authors of Georgia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia Li. A scholar is included among the top collaborators of Georgia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia Li. Georgia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Perakakis, Nikolaos, Aditya Joshi, Natia Peradze, et al.. (2020). The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis. Hepatology Communications. 4(9). 1302–1315. 15 indexed citations
2.
Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, et al.. (2019). The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.. Hepatology. 3 indexed citations
3.
Younossi, Zobair M., Maria Stepanova, Quentin M. Anstee, et al.. (2019). Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 17(12). 2552–2560.e10. 67 indexed citations
4.
Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, et al.. (2019). The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Hepatology. 70(3). 788–801. 205 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026